BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29848180)

  • 1. Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines.
    Collins G; Mesiano S; DiFeo A
    Reprod Sci; 2019 May; 26(5):609-618. PubMed ID: 29848180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
    Cao C; Zhou JY; Xie SW; Guo XJ; Li GT; Gong YJ; Yang WJ; Li Z; Zhong RH; Shao HH; Zhu Y
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
    Hanna RK; Zhou C; Malloy KM; Sun L; Zhong Y; Gehrig PA; Bae-Jump VL
    Gynecol Oncol; 2012 May; 125(2):458-69. PubMed ID: 22252099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.
    Pabona JMP; Burnett AF; Brown DM; Quick CM; Simmen FA; Montales MTE; Liu SJ; Rose T; Alhallak I; Siegel ER; Simmen RC
    Reprod Sci; 2020 Jan; 27(1):267-277. PubMed ID: 32046384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.
    Cantrell LA; Zhou C; Mendivil A; Malloy KM; Gehrig PA; Bae-Jump VL
    Gynecol Oncol; 2010 Jan; 116(1):92-8. PubMed ID: 19822355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
    Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
    Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
    Zhang J; Zhang B; Yin Z; Chen F; Liu T; Xu H; Liu Y; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):932-7. PubMed ID: 25608995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
    Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
    Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of endometrial cancer cells from primary human tumor samples to new potential anticancer peptide lactaptin.
    Koval OA; Sakaeva GR; Fomin AS; Nushtaeva AA; Semenov DV; Kuligina EV; Gulyaeva LF; Gerasimov AV; Richter VA
    J Cancer Res Ther; 2015; 11(2):345-51. PubMed ID: 26148598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
    Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
    Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A20-mediated deubiquitination of ERα in the microenvironment of CD163
    Lv Q; Xie L; Cheng Y; Shi Y; Shan W; Ning C; Xie B; Yang B; Luo X; He Q; Zhu Q; Zhang Y; Zhang Z; Wang C; Chen X; Xu C
    Cancer Lett; 2019 Feb; 442():137-147. PubMed ID: 30420335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells.
    Zhang J; Xu H; Zhou X; Li Y; Liu T; Yin X; Zhang B
    Oncol Lett; 2017 Oct; 14(4):4949-4956. PubMed ID: 29085506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
    Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
    PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer.
    Liu J; Wang Z; Zhou J; Wang J; He X; Wang J
    Chin Med J (Engl); 2023 Nov; 136(21):2576-2586. PubMed ID: 37144734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.
    Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW
    Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
    Wang J; Shi H; Xie Y; Peng Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
    Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.
    Sun PM; Gao M; Wei LH; Mustea A; Wang JL; Könsgen D; Lichtenegger W; Sehouli J
    Int J Gynecol Cancer; 2006; 16 Suppl 2():564-8. PubMed ID: 17010074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
    Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.